CXCL12 (SDF-1)/CXCR4 pathway in cancer
Beverly A Teicher1, Simon P Fricker
1Genzyme Corporation, Framingham, Massachusetts 01701-9322, USA. Beverly.Teicher@Genzyme.com
Abstract:
Chemokines, small proinflammatory chemoattractant cytokines that bind to specific G-protein-coupled seven-span transmembrane receptors, are major regulators of cell trafficking and adhesion. The chemokine CXCL12 [stromal cell-derived factor-1 (SDF-1)] binds primarily to CXC receptor 4 (CXCR4; CD184). The binding of CXCL12 to CXCR4 induces intracellular signaling through several divergent pathways initiating signals related to chemotaxis, cell survival and/or proliferation, increase in intracellular calcium, and gene transcription. CXCR4 is expressed on multiple cell types including lymphocytes, hematopoietic stem cells, endothelial and epithelial cells, and cancer cells. The CXCL12/CXCR4 axis is involved in tumor progression, angiogenesis, metastasis, and survival. This pathway is a target for therapeutics that can block the CXCL12/CXCR4 interaction or inhibit downstream intracellular signaling.
More Related Videos
Related Concept Videos
Chemotaxis and Direction of Cell Migration
Cancer Cell Migration through Invadopodia
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Canonical Wnt Signaling Pathway
Regulation of Hematopoietic Stem Cells


